Oral administration of Escherichia coli glutamic acid decarboxylase has immunomodulatory effects in streptozotocin-induced diabetes

Microbios

Volumn 102, Issue 403, 2000, Pages 135-145

  Yazdchi Marandi, L ^a   Yazdanparast, R ^b   Rafieii, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Escherichia coli; Glutamic acid decarboxylase; Streptozotocin

Indexed keywords

ANTIBODY; CONCANAVALIN A; GLUTAMATE DECARBOXYLASE; STREPTOZOCIN;

ANIMAL; ARTICLE; BLOOD; CYTOLOGY; ENZYMOLOGY; ESCHERICHIA COLI; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES; CONCANAVALIN A; DIABETES MELLITUS, EXPERIMENTAL; ESCHERICHIA COLI; GLUTAMATE DECARBOXYLASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; STREPTOZOCIN;

EID: 0033642266     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BACH J. F., Khoutouzou S. and Van-Endert P. M. 1998. Are there unique autoantigens triggering autoimmune diseases? Immunol. Rev. 164 139-55.
2. BAEKKESKOV S., Aanstoot H. J. and Christgou S. 1990. Identification of the 64k-autoantigen in insulin-dependent diabetes as the GABA-sythesizing enzyme glutamic acid decarboxylase. Nature 347 151-6.
3. CASTANO L. and Eisenbarth G. S. 1990. Type 1 diabetes: a chronic disease of human, mouse and rat. A. Rev. Immunol. 8 647-79.
4. CZERKINSKY C., Sun J. B., Lebens M., Li B. L., Rask C., Lindblad M. and Holmgren J. 1996. Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity. Ann. N.Y. Acad. Sci. 778 185-93.
5. DIAZ J. L., Ways J. and Hammonds P. 1992. T lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K β-cell antigen of IDDM. Diabetes 41 118-21.
6. ELIAS D., Prigozin H., Polak N., Rapaport M., Lohse A. W. and Cohen I. R. 1994. Autoimmune diabetes induced by the β-cell toxin STZ. Diabetes 43 992-8.
7. 67) prevents autoimmune diabetes in NOD mice. Diabetes 43 1494-9.
8. ELSON C. O., Tomasi M., Detzbaugh M. T., Thaggard G., Hunter R. and Weaver C. 1996. Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. Ann. N.Y. Acad. Sci. 778 156-62.
9. ESPOSTI M. D. and Mackay I. R. 1997. The GABA network and the pathogenesis of IDDM. Diabetologia 40 352-6.
10. HERBRINK P., Van Bussel F. J. and Warnaar S. O. 1982. The antigen spot test (AST): a highly sensitive assay for the detection of antibodies. J. Immunol. Meth. 48 293-8.
11. + T cells. Diabetes 44 354-9.
12. HIBI T. and Saito Y. 1985. A dot immunobinding assay for the detection of tobacco mosaic virus in infected tissues. J. gen. Virol. 66 1191-4.
13. HUANG W. M., Reed-Fourquet L., Wu E. and Wu J. Y. 1990. Molecular cloning and amino acid sequence of brain L-glutamate decarboxylase. Proc. natn. Acad. Sci. U.S.A. 87 8491-5.
14. KHOURY S. J., Lider O., Al-Sabbagh A. and Weiner H. L. 1990. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol. 131 302-10.
15. 67 in pancreatic Islets of man, rat and mouse. Diabetes 42 1799-808.
16. MILLER A., Lider O., Roberts A. B., Sporn M. B. and Weiner H. L. 1992. Suppressor T cells generated by oral tolerization of myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor-β after antigen-specific triggering. Proc. natn. Acad. Sci. U.S.A. 39 421-5.
17. NEPOM G. T. 1995. Glutamic acid decarboxylase and other autoantigens in IDDM. Curr. Opin. Immunol. 7 825-30.
18. PAPACCIO G., Esposito V. and Mezzogiorno V. 1989. Multiple low dose streptozotocin-treated rats. Biochemical and morphological effects of cyclosporin A administration. Cell. molec. Biol. 35 409-20.
19. PASSONNEAU J. V. and Lowry O. H. 1993. Glutamate decarboxylase (EC 4.1.1.15). In Enzymatic Analysis, a Practical Guide. First editn. pp 256-8. Humana Press Inc., Totowa, New Jersey, U.S.A.
20. 65). Clin. Immunol. Immunopathol. 76 90-5.
21. SAI P., Rivereau A. S., Granier C., Haertle T. H. and Martignat L. 1996. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin. exp. Immunol. 105 330-7.
22. SODA K. and Osumi T. 1969. Measurement of L-glutamate formed from D-glutamate (L-glutamate decarboxylase). Meth. Enzymol. 17B 631.
23. STROBER W., Kelsall B. and Marth T. 1998. Oral tolerance. J. Clin. Immunol. 18 1-30.
24. 2 responses and prevents murine insulin-dependent diabetes. J. exp. Med. 183 1561-7.
25. 2 autoimmunity in diabetes-prone mice. Immunol. Rev. 164 119-27.
26. TISCH R. and McDevitt H. 1996. Insulin-dependent diabetes mellitus. Cell 85 291-7.
27. TISCH R., Yang X. D., Liblau R. and McDevitt H. O. 1994. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J. Autoimmun. 7 845-50.
28. TRENTHAM D. E., Dynesius-Trentham R. A., Orav E. J., Combatchi D., Lorenzo C., Sewell K. L., Hatler D. A. and Weiner H. L. 1993. Effects of oral administration of Type II collagen on rheumatoid arthritis. Science 261 1727-30.
29. WALKER J. M. 1996a. Nondenaturing polyacrylamide gel electrophoresis of proteins. In The Protein Protocols Handbook. First editn. pp 51-4. Humana Press Inc., Totowa, New Jersey, U.S.A.
30. WALKER J. M. 1996b. SDS polyacrylamide gel electrophoresis of proteins. In The Protein Protocols Handbook. First editn. pp 55-62. Humana Press Inc., Totowa, New Jersey, U.S.A.
31. WEINER H. L., Friedman A., Miller A., Khoury S. J., Al-Sabbagh A., Santos L, Sayegh M., Nussenblatt R. B., Trentham D. E. and Hafler D. A. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. A. Rev. Immunol. 12 809-37.
32. YANG B. I. J. and Metzler D. E. 1979. Pyridoxal 5′-phosphate and analogs as probes of coenzyme-protein interaction. Meth. Enzymol. 62 528-51.
33. ZECHAL M. A., Krawetz M. D. and Singh B. 1998. Epitope dominance: evidence for reciprocal determinant spreading in glutamic acid decarboxylase in nonobese diabetic mice. Immunol. Rev. 164 111-8.
34. ZHANG Z. J., Davidson L., Eisenbarth G. and Weiner H. L. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. natn. Acad. Sci. U.S.A. 88 10252-6.